Valeant to sell its Obagi skin-care business for US$190 million to H.K. group

  • About: 12 days ago
  • 5 views
Valeant to sell its Obagi skin-care business for US$190 million to H.K. group - World News

LAVAL, Que. — Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.


The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.


The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.

Related Tags

#cp



Loading...



Loading...




Content from our sponsored near by you